Myxoid liposarcoma is a rare cancer that starts in your fat cells. You can have this condition for several years before noticing symptoms, like a visible lump under the skin on your legs or arms. The most common treatments for tumors that haven’t spread are surgery and radiation therapy. Other treatments are chemotherapy and targeted therapy.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Myxoid liposarcoma (MLPS) is a type of liposarcoma, a group of rare cancers that begin in fat cells. You can have this condition for years before having symptoms, like a lump under the skin on your legs or arms.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Most myxoid liposarcoma tumors grow slowly. That said, high-grade tumors often spread to nearby soft tissue, like muscle and skin. The cancer can also spread to organs or bones, like your pelvis or spine.
Another name for high-grade MLPS is myxoid round cell liposarcoma. It gets its name from the round cells that healthcare providers see when they look at the cancer cells under a microscope.
Providers most often use surgery and radiation therapy to treat tumors that haven’t spread (localized disease). You may need cancer drugs that travel throughout your body, like chemotherapy, to treat MLPS that has spread (metastases).
The most common sign is a slow-growing lump under your skin. Usually, it’s in the deep tissue in your leg (especially your thigh) or arms. Tumors can also form in your chest, abdomen or pelvis. Sometimes, large tumors cause symptoms, such as:
This condition happens when part of one chromosome breaks off and attaches to a different chromosome. This causes a fusion gene to form. The mix-up turns normal cells into cancer cells that form tumors. There are two main types of fusion genes linked to MLPS:
Advertisement
Your provider will look for these genes to confirm your diagnosis.
Healthcare providers don’t know what causes the gene mix-up in the first place. They do know that most people diagnosed are between 30 and 50. But it can affect people of all ages.
Your provider will do a physical exam and ask about your symptoms. Tests they may use include:
Healthcare providers stage myxoid liposarcoma to see how advanced it is. They use the TNM staging system. It considers things like the tumor’s size and whether disease has spread to your lymph nodes or distant organs.
Grading is especially important. Providers assign a grade to the cancer based on how the cells look under a microscope. High-grade cancers are likely to spread.
Myxoid liposarcoma is high-grade if more than 5% of the cancer cells in a biopsy sample are round cells. Once, providers thought of “round cell liposarcoma” as a different cancer type. Now, it’s considered an aggressive form of myxoid liposarcoma.
Your provider may use one or a combination of the following treatments:
You’ll need regular check-ups even if treatment sends disease into remission. Remission means there aren’t any signs or symptoms of cancer. This is because tumors can come back as new tumors where cancer first started. Sometimes, they show up in a different area of your body.
How often you’ll need follow-ups depends on the tumor grade or stage. Usually, they’re more frequent within the first three years. This is when the chances of tumors coming back are highest.
Advertisement
In general, people who get treatment for localized disease have a better outlook than people with tumors that have spread. Other things that often forecast a better prognosis include:
Your healthcare provider is your best resource for information about what you may expect, given your situation.
It can be placed in remission, meaning treatment eliminates all signs and symptoms of myxoid liposarcoma. But it may come back.
Your healthcare provider will monitor you closely, so they can detect recurrence early, when treatments work best.
According to a recent study, the five-year survival rate of MLPS is 79%. The 10-year survival rate is 66%. This means that nearly 8 out of 10 people are alive five years after their diagnosis, and a little fewer than 7 in 10 are alive 10 years later.
It’s important to remember that survival rates are estimates. Experts develop survival rate estimates by reviewing the experiences of others with the same condition. What’s true for those people may not be true for you. Also, these numbers don’t account for important differences, like cancer stage and grade.
Advertisement
Your healthcare provider is the best resource for understanding your timeline.
If you have myxoid liposarcoma (MLPS), it’s important to know how the stage and grade impact your treatment. This information can also help you understand what results you may expect. Often, surgery and radiation therapy send localized disease into remission. But even then, these cancers can come back. This is why it’s essential to lean on your healthcare provider for information and support. They’ll help you understand how this diagnosis will shape your next steps.
Advertisement
Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more.
Learn more about the Health Library and our editorial process.
Cleveland Clinic’s health articles are based on evidence-backed information and review by medical professionals to ensure accuracy, reliability and up-to-date clinical standards.
Cleveland Clinic’s health articles are based on evidence-backed information and review by medical professionals to ensure accuracy, reliability and up-to-date clinical standards.
Sarcomas are a rare form of cancer affecting your bones and soft tissues. Our specialists use the latest treatments to care for these types of tumors.
